Get smoker to their baseline for their behavioral health condition and initiating abstinence from substances. Then assess whether, in the past year, was.

Slides:



Advertisements
Similar presentations
NC STEP/Mission Hospitals School Cessation and Treatment Guide.
Advertisements

A Clinical Flow-Chart for the “Treatment-Resistant Smoker”
Jean-François ETTER Evelyne LASZLO Jean-Pierre ZELLWEGER Charles PERROT Thomas PERNEGER University of Geneva, Switzerland Smoking reduction with NRT: a.
Medicaid & Tobacco Dependence Treatment Mental Health and Substance Abuse Adult smoking among Medicaid recipients is 50 percent higher than the adult population.
STAGES OF CHANGE Precontemplation Contemplation Action Maintenance Relapse Not yet considering quitting Thinking about quitting Making a quit attempt Remaining.
Treating Tobacco Dependence Ask your patients about tobacco use Act to help them quit.
ABCs of Behavioral Support Jonathan Foulds PhD. Penn State – College of Medicine
Treatment of Tobacco Dependence in 2012 J. Taylor Hays, MD Professor of Medicine Associate Director Nicotine Dependence Center Mayo Clinic Rochester, MN.
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Key Public Health issues of smoking Passive smoking in home, car, workplace, restaurants etc. Self- induced disease and cost of smoking related diseases.
Nicotine Replacement Therapy: Administration and Overview Barbara Hart, MPA and Claudia Lechuga, MS Bronx BREATHES T: (718) E:
Prevention strategies
Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.
Treating Nicotine Dependence in Patients with Addictive Disorders Eric Heiligenstein, M.D. Director of Psychiatry University Health Services University.
Pharmacotherapy for the Treatment of Nicotine Dependence Donna Shelley, MD, MPH, Columbia University Mailman School of Public Health
QUIT NOW. BARRIERS TO QUITTING Nicotine is a potent psychoactive drug that causes physical dependence and tolerance. In the absence of nicotine, a smoker.
1 CTRI Webinar: Combination Medication Effectiveness June 9, 2010 Stevens S. Smith, Ph.D. Megan E. Piper, Ph.D. Center for Tobacco Research & Intervention.
Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Treating Tobacco Use.
Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)
Nicotine-related disorders Answers obtained from DSM-IV-TR and the AJP Supplement of August, 2006, on substance abuse As of 1Sep08.
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Why People with Mental Health Conditions Smoke So Much and What To Do About It John Hughes University of Vermont, USA
An Updated Algorithm for Choosing Among Smoking Cessation Treatments John R. Hughes University of Vermont, USA
Treating Tobacco Dependence Ask your patients about tobacco use Act to help them quit.
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
Nicotine dependence It’s in ICD 10! MRCPsych addiction psychiatry seminars March 2010.
New Plan Provisions- Medical Plan Changes. 2 Tobacco/Smoking Cessation Support “Clearing the Air” to a Tobacco-Free UC on January 2, 2014 Effective January.
July 2006 Treating Tobacco Use and Dependence. Learning Objectives At the end of this session you should understand: The impact of tobacco dependence.
SMOKING in ADOLESCENTS with PSYCHIATRIC or ADDICTIVE DISORDERS.
Melissa Natzke Doctor of Pharmacy Candidate
Attempting to increase the use of smoking cessation medications Brendon Baker Ministry of Health.
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
Smoking. Why people smoke and find it difficult to stop Smoking is an addictive habit. It is associated with strong cravings, dependency, tolerance, and.
1 Should behavioural support for smoking cessation address wider psychological problems? University College London October 2013 Robert West.
AN EXAMINATION OF THE PRACTICE OF TAILORING SMOKING CESSATION PHARMACOTHERAPY IN A TOBACCO TREATMENT PROGRAM WITHIN MENTAL HEALTH AND ADDICTIONS SETTINGS.
Evidence-based medication treatment of tobacco use disorder in people with mental health and addictions 2016.
Pharmacotherapy for Smoking Cessation
Conclusions and Awards
Quick overview of quit smoking counseling for people with mental health or substance use disorders Associate Professor of.
Unit 14 – Exercise, Health and Lifestyle
Smoking Cessation Medication
6 myths and facts about tobacco use disorder in people with mental health and substance use disorders Associate Professor.
Anita R. Webb, PhD JPS Family Medicine Residency
screening, brief intervention, and referral to treatment
Assistant professor Family Medicine - Suez Canal University
Meta-analysis of Effectiveness of First-Line Smoking Cessation Pharmacotherapies 6 Months After Quitting Medication Estimated OR (95% CI) Est. abstinence.
FDA Authority to Regulate Tobacco Products Tobacco Control Act
Smoking and smoking cessation in the real world
Development and Implementation of a Tobacco Cessation Toolkit
Why and How to Quit Smoking
Robert West University College London London March 2008
New Labelling for Nicoderm® and Nicorette®
Update Smoking Cessation
BTEC National Diploma in Sport
Tobacco Dependence Screening and Treatment in Behavioral Health Settings Prescribing.
Tobacco Cessation Guidelines for COPD
Treating Tobacco Dependence
Forming a Tobacco Addiction
Nicotine replacement therapy
Nicotine Dependence and Treatment
ABCs of Behavioral Support
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
عوامل الخطر للتدخين في إقليم شرق المتوسط د
Age inequity and Smoking Cessation
Mini Lesson #1 – Smoking Cessation
Session #5 Medication.
Pharmacotherapy CAN-ADAPTT Guideline Webinar Series March 1, 2011
Presentation transcript:

Get smoker to their baseline for their behavioral health condition and initiating abstinence from substances. Then assess whether, in the past year, was this patient: Suicidal or homicidal Significantly depressed Violent Unwilling to attend regular doctor’s appointments to monitor medications Under 18 years old A Guide for Choosing Smoking Cessation Medication in Mental Illness/addiction Tailoring based on research evidence (ANTHENELLI 2016; Bader 2009; Fiore 2008; Piper 2009; Evins 2010; Hitsman 2009) No to all VARENICLINE 3. Does patient: Smoke 20 or more cigarettes a day Have a history of failure at serious quit attempts Have nicotine withdrawal when patient stops smoking, or Failure on single daily low dose of NRT Yes to any 2. Does patient have a history of: Mania Anxiety disorder Seizure Eating disorder Under 18 years old No to all Yes to any No to all BUPROPION + High dose combination NRT BUPROPION +Low dose combination NRT Yes to any 4. Does patient: Smoke 20 or more cigarettes a day Have nicotine withdrawal when patient stops smoking, or Have a history of failure at serious Failure on single daily low dose of NRT quit attempt Yes to any No to all High dose combination NRT Low dose combination NRT Combination Nicotine Replacement Therapy (NRT): High dose NRT: 21mg patch plus immediate release Low dose NRT: 14mg patch plus immediate release Immediate release: gum, lozenge, spray or inhaler up to 8 X day at appropriate strength. (Gum and lozenge come in either 2mg or 4 mg strength.)